These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19908840)

  • 21. Leveraging the cruzain S3 subsite to increase affinity for reversible covalent inhibitors.
    Cianni L; Sartori G; Rosini F; De Vita D; Pires G; Lopes BR; Leitão A; Burtoloso ACB; Montanari CA
    Bioorg Chem; 2018 Sep; 79():285-292. PubMed ID: 29783099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds.
    Alves VM; Yasgar A; Wellnitz J; Rai G; Rath M; Braga RC; Capuzzi SJ; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
    J Med Chem; 2023 Sep; 66(18):12828-12839. PubMed ID: 37677128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library.
    Shah F; Mukherjee P; Gut J; Legac J; Rosenthal PJ; Tekwani BL; Avery MA
    J Chem Inf Model; 2011 Apr; 51(4):852-64. PubMed ID: 21428453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies.
    Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD
    J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apparent activity in high-throughput screening: origins of compound-dependent assay interference.
    Thorne N; Auld DS; Inglese J
    Curr Opin Chem Biol; 2010 Jun; 14(3):315-24. PubMed ID: 20417149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of dipeptidyl alpha',beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain.
    Roush WR; González FV; McKerrow JH; Hansell E
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2809-12. PubMed ID: 9873627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of Gallinamide A Analogs as Potent Inhibitors of the Cysteine Proteases Human Cathepsin L and
    Boudreau PD; Miller BW; McCall LI; Almaliti J; Reher R; Hirata K; Le T; Siqueira-Neto JL; Hook V; Gerwick WH
    J Med Chem; 2019 Oct; 62(20):9026-9044. PubMed ID: 31539239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors.
    Liu Y; Lu WQ; Cui KQ; Luo W; Wang J; Guo C
    Arch Pharm Res; 2012 Sep; 35(9):1525-31. PubMed ID: 23054708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
    Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
    Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.
    Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
    Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
    J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.
    Rocha DA; Silva EB; Fortes IS; Lopes MS; Ferreira RS; Andrade SF
    Eur J Med Chem; 2018 Sep; 157():1426-1459. PubMed ID: 30282318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCAM Detective: Accurate Predictor of Small, Colloidally Aggregating Molecules.
    Alves VM; Capuzzi SJ; Braga RC; Korn D; Hochuli JE; Bowler KH; Yasgar A; Rai G; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
    J Chem Inf Model; 2020 Aug; 60(8):4056-4063. PubMed ID: 32678597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An altered zinc-binding site confers resistance to a covalent inactivator of New Delhi metallo-beta-lactamase-1 (NDM-1) discovered by high-throughput screening.
    Thomas PW; Spicer T; Cammarata M; Brodbelt JS; Hodder P; Fast W
    Bioorg Med Chem; 2013 Jun; 21(11):3138-46. PubMed ID: 23591260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescence-quenching-based homogeneous caspase-3 activity assay using photon upconversion.
    Vuojola J; Riuttamäki T; Kulta E; Arppe R; Soukka T
    Anal Chim Acta; 2012 May; 725():67-73. PubMed ID: 22502613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cruzain : the path from target validation to the clinic.
    Sajid M; Robertson SA; Brinen LS; McKerrow JH
    Adv Exp Med Biol; 2011; 712():100-15. PubMed ID: 21660661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
    Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CoMFA and HQSAR of acylhydrazide cruzain inhibitors.
    Rodrigues CR; Flaherty TM; Springer C; McKerrow JH; Cohen FE
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1537-41. PubMed ID: 12031337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania major: molecular modeling of cysteine proteases and prediction of new nonpeptide inhibitors.
    Selzer PM; Chen X; Chan VJ; Cheng M; Kenyon GL; Kuntz ID; Sakanari JA; Cohen FE; McKerrow JH
    Exp Parasitol; 1997 Nov; 87(3):212-21. PubMed ID: 9371086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.